Kiniksa Pharmaceuticals, Ltd. (KNSA): KNSA inching back up

Monksdream · 2024-09-15T16:54:53.2530000Z

KNSA inching back up https://investorshub.advfn.com/uimage/uploads/2024/9/15/lohb[IMG_1813.gif

Kiniksa Pharmaceuticals, Ltd. (KNSA)

Reply Private New

Keep Last Read

Prev Next

Monksdream

Send PM Follow Ignore

Followers	309
Posts	63051
Boards Moderated	9
Alias Born	08/29/2007

Monksdream

Re: None

Sunday, 09/15/2024 12:54:53 PM

Sunday, September 15, 2024 12:54:53 PM

KNSA inching back up

I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/

Keep Last Read

Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent KNSA News

Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/18/2025 08:39:56 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/16/2025 09:23:34 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/11/2025 08:39:16 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/10/2025 09:46:31 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/09/2025 09:09:32 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2025 08:46:35 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2025 08:38:56 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/05/2025 11:10:35 AM
Kiniksa Pharmaceuticals Announces Trial Design of Planned Phase 2/3 Clinical Trial of KPL-387 in Recurrent Pericarditis • GlobeNewswire Inc. • 06/05/2025 11:00:00 AM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2025 08:35:14 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2025 08:34:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/03/2025 08:30:39 PM
Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/29/2025 08:01:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/09/2025 09:01:05 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/09/2025 08:32:09 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/07/2025 08:59:33 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2025 08:54:51 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2025 08:53:14 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/05/2025 08:47:42 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/05/2025 08:11:28 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/02/2025 09:01:31 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2025 10:26:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/01/2025 10:24:33 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2025 09:11:26 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/01/2025 09:10:31 PM

More KNSA News

InvestorsHub NewsWire

FEATURED Aspire Biopharma Holdings, Inc., Announces Positive Consumer Feedback from Company Sampling of BUZZ BOMB™, its New Sublingual Pre-Workout Supplement • Jul 9, 2025 9:15 AM

Breaking Through: Systemic Genetic Medicines for Hard-to-Treat Cancers • IBRX • Jul 9, 2025 9:00 AM

Fifty 1 Labs, Inc. Announces Bold Expansion Plan Powered by Nobel Prize Laureate Management Team, Cutting-Edge AI Healthcare Innovation and $350K Leadership Investment • FITY • Jul 8, 2025 8:30 AM

Avant Technologies and Partner, Ainnova, Launch Transformative Preventative Care Model for Chronic Patients Across Latin America • AVAI • Jul 8, 2025 8:00 AM

Precision Genetic Medicine Platform Could Disrupt Standard of Care in Metastatic Cancer, Other Indications of Unmet Needs • CLDI • Jul 7, 2025 9:00 AM

VAYK Discloses More Insider Buying Approaching 15 Million • VAYK • Jul 2, 2025 10:37 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent KNSA News

More KNSA News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent KNSA News

Go Ad-Free